Corrigendum: immune checkpoint inhibitor therapy increases systemic sdf-1, cardiac damps fibronectin-eda, s100/calgranulin, galectine-3, and nlrp3-myd88-chemokine pathways

HIGHLIGHTS

SUMMARY

Immunotherapy, biomarkers, preclinical study, mechanisms, inflammation, interleukin A corrigendum on Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways by Quagliariello, V. In the published article, there was an error in the Data Availability statement. The original statement incorrectly read: "The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation." The correct Data Availability statement appears below: "The data presented in the study are deposited in the Zenodo repository, accession number https://zenodo . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.